Fosciclopirox

CAS No. 1380539-06-9

Fosciclopirox( CPX-POM )

Catalog No. M28675 CAS No. 1380539-06-9

Fosciclopirox, the phosphoryloxymethyl ester of CPX (Ciclopirox Prodrug, CPX-POM), selectively delivers the active metabolite, CPX, to the entire urinary tract following parenteral administration.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 50 In Stock
2MG 29 In Stock
5MG 46 In Stock
10MG 79 In Stock
25MG 164 In Stock
50MG 254 In Stock
100MG 375 In Stock
200MG 533 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Fosciclopirox
  • Note
    Research use only, not for human use.
  • Brief Description
    Fosciclopirox, the phosphoryloxymethyl ester of CPX (Ciclopirox Prodrug, CPX-POM), selectively delivers the active metabolite, CPX, to the entire urinary tract following parenteral administration.
  • Description
    Fosciclopirox, the phosphoryloxymethyl ester of CPX (Ciclopirox Prodrug, CPX-POM), selectively delivers the active metabolite, CPX, to the entire urinary tract following parenteral administration.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    CPX-POM
  • Pathway
    Neuroscience
  • Target
    Gamma-secretase
  • Recptor
    ——
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1380539-06-9
  • Formula Weight
    317.278
  • Molecular Formula
    C13H20NO6P
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 100 mg/mL (315.19 mM)
  • SMILES
    Cc1cc(C2CCCCC2)n(OCOP(O)(O)=O)c(=O)c1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Faria DB, et al. Effects of lidocaine and droxicainide on myocardial necrosis: a comparative study. J Am Coll Cardiol. 1983 Jun;1(6):1447-52.
molnova catalog
related products
  • PEAQX

    PEAQX(NVP-AAM 077) is an effective and orally available NMDA antagonist. It can inhibit human NMDA receptors for 1A/2A(IC50: 270 nM), rather than 1A/2B(29, 600 nM).

  • Compound W

    The compound is an inhibitor of γ-secretase. It also causes a decrease in the released levels of Aβ42 and notch-1 Aβ-like peptide 25 (Nβ25).

  • LY900009

    LY900009 is a small molecule inhibitor of Notch signalling via selective inhibition of the γ-secretase protein.?